{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T05:12:45Z","timestamp":1716613965706},"reference-count":76,"publisher":"Oto-Rhino-Laryngological Society of Japan, Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Jibiinkoka Gakkai Kaiho"],"published-print":{"date-parts":[[2012]]},"DOI":"10.3950\/jibiinkoka.115.73","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T04:19:48Z","timestamp":1333340388000},"page":"73-84","source":"Crossref","is-referenced-by-count":2,"title":[""],"prefix":"10.3950","volume":"115","member":"2345","reference":[{"key":"1","unstructured":"1) zur Hausen H: Papillomaviruses in human cancer. Appl Pathol 1987; 5: 19-24."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hobbs CG, Sterne JA, Bailey M, et al: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31: 259-266.","DOI":"10.1111\/j.1749-4486.2006.01246.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8.","DOI":"10.1016\/S0002-9343(97)00177-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Bosch FX, Lorincz A, Munoz N, et al: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.","DOI":"10.1136\/jcp.55.4.244"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) de Villiers EM: Papillomavirus and HPV typing. Clin Dermatol 1997; 15: 199-206.","DOI":"10.1016\/S0738-081X(96)00164-2"},{"key":"8","unstructured":"8) International Agency for Research on Cancer: Human papillomaviruses. Lyon; 2006 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 90)."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"10","unstructured":"10) NIH Consensus Statement: Cervical cancer. NIH Consens Statement 1996; 14: 1-38."},{"key":"11","unstructured":"11) World Health Organization: IARC monograph on the evaluation of carcinogenic risks to humans: human papillomaviruses. 1995. Lyons, France, IARC; 2000."},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Parkin DM, Bray F: The burden of HPV-related cancers. Vaccine 2006; 24: S11-S25.","DOI":"10.1016\/j.vaccine.2006.05.111"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bosch FX: Human papillomavirus and cervical cancer&mdash;burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Clifford GM, Smith JS, Aguado T, et al: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-105.","DOI":"10.1038\/sj.bjc.6601024"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Clifford G, Franceschi S, Diaz M, et al: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24: S26-S34.","DOI":"10.1016\/j.vaccine.2006.05.026"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Franco EL, Villa LL, Sobrinho JP, et al: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180: 1415-1423.","DOI":"10.1086\/315086"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Moscicki AB, Shiboski S, Broering J, et al: The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132: 277-284.","DOI":"10.1016\/S0022-3476(98)70445-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Myers ER, McCrory DC, Nanda K, et al: Mathematical model for the natural history of humanpapillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151: 1158-1171.","DOI":"10.1093\/oxfordjournals.aje.a010166"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Castle PE, Schiffman M, Herrero R, et al: A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1808-1816.","DOI":"10.1086\/428779"},{"key":"22","unstructured":"22) Kjaer SK, Chackerian B, van den Brule AJ, et al: High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10: 101-106."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ho GY, Burk RD, Klein S, et al: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-1371.","DOI":"10.1093\/jnci\/87.18.1365"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Schiffman M, Kjaer SK: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31: 14-19.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Moscicki AB, Schiffman M, Kjaer S, et al: Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24: S42-S51.","DOI":"10.1016\/j.vaccine.2006.06.018"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wheeler CM, Hunt WC, Schiffman M, et al: Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006; 194: 1291-1299.","DOI":"10.1086\/507909"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Winer RL, Lee SK, Hughes JP, et al: Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218-226.","DOI":"10.1093\/aje\/kwf180"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Fairley CK, Gay NJ, Forbes A, et al: Hand-genital transmission of genital warts? An analysis of prevalence data. Epidemiol Infect 1995; 115: 169-176.","DOI":"10.1017\/S0950268800058234"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Rintala MA, Grenman SE, Jarvenkyla ME, et al: High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 2005; 41: 1728-1733.","DOI":"10.1086\/498114"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Castellsague X, Munoz N: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives,and tobacco smoking. J Natl Cancer Inst Monogr 2003; 31: 20-28.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Clifford GM, Goncalves MA, Franceschi S: Human papillomavirus types among women infected with human immunodeficiency virus: a meta-analysis. AIDS 2006; 20: 2337-2344.","DOI":"10.1097\/01.aids.0000253361.63578.14"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Palefsky JM: Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23: 15-20.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024166"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11691"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Stanley M: Immune responses to human papillomavirus. Vaccine 2006; 24: S16-S22.","DOI":"10.1016\/j.vaccine.2005.09.002"},{"key":"35","unstructured":"35) Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec 2009; 84: 118-131."},{"key":"36","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Paavonen J, Naud P, Salmeron J, et al: Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374: 301-314.","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Konno R, Tamura S, Yoshikawa H, et al: Efficacy of Human Papillomavirus Type 16\/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years: Final Analysis of a Phase 2 Double-Blind, Randomized Controlled Trial. Int J Gynecol Cancer 2010; 20: 847-855.","DOI":"10.1111\/IGC.0b013e3181da2128"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Konno R, Sasagawa T, Fukuda T, et al: Cost-effectiveness analysis of prophylactic cervical cancer vaccination in Japanese women. Int J Gynecol Cancer 2010; 20: 385-392.","DOI":"10.1111\/IGC.0b013e3181d189b8"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Matsuda T, Marugame T, Kamo KI, et al: The Japan Cancer Surveillance Research Group: Cancer Incidence and Incidence Rates in Japan in 2005: Based on Data from 12 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn JClin Oncol 2011; 41: 139-147.","DOI":"10.1093\/jjco\/hyq169"},{"key":"42","unstructured":"42) \u4eba\u53e3\u52d5\u614b\u7d71\u8a08 (\u539a\u751f\u52b4\u50cd\u7701\u5927\u81e3\u5b98\u623f\u7d71\u8a08\u60c5\u5831\u90e8\u7de8)."},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065497"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0551"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Applebaum KM, Furniss CS, Zeka A, et al: Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007; 99: 1801-1810.","DOI":"10.1093\/jnci\/djm233"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Pintos J, Black MJ, N Sadeghi, et al: Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol 2008; 44: 242-250.","DOI":"10.1016\/j.oraloncology.2007.02.005"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Smith EM, Ritchie JM, Summersgill KF, et al: Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004; 96: 449-455.","DOI":"10.1093\/jnci\/djh074"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199910000-00002"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Tachezy R, Klozar J, Rubenstein L, et al: Demographic and risk factors in patients with head and neck tumors. J Med Virol 2009; 81: 878-887.","DOI":"10.1002\/jmv.21470"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn372"},{"key":"51","unstructured":"51) Romanitan M, N&auml;sman A, Ramqvist T, et al: Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res 2008; 28: 2077-2080."},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24339"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Hansson BG, Rosenquist K, Antonsson A, et al: Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 1337-1344.","DOI":"10.1080\/00016480510043945"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Brandsma JL, Abramson AL: Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989; 115: 621-625.","DOI":"10.1001\/archotol.1989.01860290079018"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Smith EM, Hoffman HT, Summersgill KS, et al: Human papillomavirus and risk of oral cancer. Laryngoscope 1989; 108: 1098-1103.","DOI":"10.1097\/00005537-199807000-00027"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1713"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Ryerson AB, Peters ES, Coughlin SS, et al: Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008; 113: 2901-2909.","DOI":"10.1002\/cncr.23745"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Shiboski CH, Schmidt BL, Jordan RC, et al: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005; 103: 1843-1849.","DOI":"10.1002\/cncr.20998"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Hammarstedt L, Lindquist D, Dahlstrand H, et al: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620-2623.","DOI":"10.1002\/ijc.22177"},{"key":"60","unstructured":"60) Dalianis T, N&auml;sman A, Attner P, et al: Human papillomavirus in tonsillar cancer, an epidemic of viral carcinoma. 25th International Papillomavirus Conference; Malm&ouml;, Sweden; May 8-14, 2009. Abstract O-17.04."},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Z Deng, M Hasegawa, S Matayoshi, et al: Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan. Eur Arch Otorhinolaryngol 2011; 268: 1625-1631.","DOI":"10.1007\/s00405-011-1515-0"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Smith EM, Ritchie JM, Summersgill KF, et al: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-772.","DOI":"10.1002\/ijc.11633"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Gillison ML, D'Souza G, Westra W, et al: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420.","DOI":"10.1093\/jnci\/djn025"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) D'Souza G, Agrawal Y, Halpern J, et al: Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-1269.","DOI":"10.1086\/597755"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Anaya-Saavedra G, Ram&iacute;rez-Amador V, Irigoyen-Camacho ME, et al: High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 2008; 39: 189-197.","DOI":"10.1016\/j.arcmed.2007.08.003"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) de Vicente JC, Gutierrez LMJ, Zapatero AH, et al: Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 2004; 26: 22-30.","DOI":"10.1002\/hed.10339"},{"issue":"16","key":"67","first-page":"3630","volume":"56","year":"1996","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Perrone F, Suardi S, Pastore E, et al: Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res 2006; 12: 6643-6651, erratum in Clin Cancer Res 2007; 13: 4313.","DOI":"10.1158\/1078-0432.CCR-06-1759"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70017-6"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Smeets SJ, Hesselink AT, Speel EJ, et al: A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472.","DOI":"10.1002\/ijc.22980"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Lindel K, Beer KT, Laissue J, et al: Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-813.","DOI":"10.1002\/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO;2-2"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(96)01806-3"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Lindquist D, Romanitan M, Hammarstedt L, et al: Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 2007; 1: 350-355.","DOI":"10.1016\/j.molonc.2007.08.005"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.","DOI":"10.1093\/jnci\/djn011"},{"key":"76","unstructured":"76) Gillison ML, Harris J, Westra W, et al: Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. 2009 ASCO annual meeting; Orlando, FL, USA; May 29-June 2, 2009. Abstract 6003."}],"container-title":["Nippon Jibiinkoka Gakkai Kaiho"],"original-title":["\u30d2\u30c8\u30d1\u30d4\u30ed\u30fc\u30de\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u3068\u5b50\u5bae\u9838\u764c\u306a\u3089\u3073\u306b\u982d\u9838\u90e8\u764c\u306e\u95a2\u308f\u308a"],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:51:46Z","timestamp":1621443106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jibiinkoka\/115\/2\/115_2_73\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.3950\/jibiinkoka.115.73","relation":{},"ISSN":["0030-6622","1883-0854"],"issn-type":[{"value":"0030-6622","type":"print"},{"value":"1883-0854","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}